Sponsor:
Flare Therapeutics Inc.
Code:
NCT07719361
Conditions
Metastatic Castration Resistant Prostate Cancer
mCRPC
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FX-111
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-02. This information was provided to ClinicalTrials.gov by Flare Therapeutics Inc. on 2026-07-24.